In a recent interview with Benefits and Pensions Monitor, Pacific Blue Cross CEO Sarah Hoffman highlighted how the province’s decision reflects a broader shift in how health systems and benefit plans must evolve to better support women at every stage of life.

As of March 1, 2026, eligible B.C. residents can access menopausal hormone therapy through BC PharmaCare’s National Pharmacare Plan (Plan NP), improving access to essential care across the province.

“B.C. is taking an important step in recognizing menopause care as essential health care,” said Sarah Hoffman, President and CEO of Pacific Blue Cross. “This is a positive step for equitable access, and it creates an opportunity for broader conversations about how benefit plans can better support women at every stage of life.”

For Pacific Blue Cross, this milestone reflects the kind of innovation the organization has long supported. As public coverage expands, private benefits continue to play an important complementary role in supporting broader health needs beyond publicly funded coverage.

This shift also highlights the growing need to address historically underrepresented areas of care, including menopause and midlife health. As women’s health conversations continue to evolve nationally, Pacific Blue Cross remains committed to advancing benefit solutions that are more inclusive, responsive, and aligned with real health needs.

Read Sarah’s full interview in Benefits and Pensions Monitor.

Looking for information about how Plan NP affects you? Learn more:

• Members
• Plan Sponsors
• Advisors
• Providers